HER2-Low Breast Carcinoma — Trials

HER2-Low Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

24 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 14
Recruiting: 12
Ph III recruiting: 1
Growth YoY: —
Industry share: 14%
Top sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06144944	Neoadjuvant Pyrotinib in HR-positive and HER2-low High-risk Early Breast Cancer	active not recruiting	Phase 3	160	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER	1	Aug 18, 2026	clinicaltrials
NCT06957886	A Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With HER2-low Recurrent/Metastatic Breast Cancer	recruiting	Phase 3	566	Sichuan Baili Pharmaceutical Co., Ltd.INDUSTRY	1	Jan 21, 2026